A newly approved ‘living drug’ could save more cancer patients’ lives
Tumor-infiltrating lymphocyte, or TIL, therapy is the first T cell treatment for solid tumors. It fights melanoma and maybe other cancers too.

Dec 8, 2024 0 1.8k
Jan 28, 2025 0 389
Sep 21, 2024 0 360
Nov 21, 2024 0 291
May 7, 2024 0 245
News headlines uses cookies. By continuing to browse the site you are agreeing to our TERMS and to use of cookies.